{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T20:05:18Z","timestamp":1760299518740},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T00:00:00Z","timestamp":1577404800000},"content-version":"vor","delay-in-days":9067,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[1995,3]]},"DOI":"10.1093\/oxfordjournals.annonc.a059148","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T12:09:11Z","timestamp":1486123751000},"page":"208-210","source":"Crossref","is-referenced-by-count":12,"title":["Mantle cell lymphoma: A therapeutic dilemma"],"prefix":"10.1016","volume":"6","author":[{"given":"B.","family":"Coiffier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Hiddemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2141.1975.tb00911.x","article-title":"The histopathology of malignant lymphoma","volume":"31","author":"Lennert","year":"1975","journal-title":"Brit J Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/ajcp\/68.5.535","article-title":"Alkaline phosphatase-positive malignant lymphoma. A subtype of B-cell lymphomas","volume":"68","author":"Nanba","year":"1977","journal-title":"Am J Clin Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0070","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/1097-0142(19810915)48:6<1415::AID-CNCR2820480625>3.0.CO;2-N","article-title":"Malignant lymphoma, intermediate lymphocytic type: A clinicopathologic study of 42 cases","volume":"48","author":"Weisenburger","year":"1981","journal-title":"Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0075","doi-asserted-by":"crossref","first-page":"9638","DOI":"10.1073\/pnas.88.21.9638","article-title":"PRAD1, a candidate BCL1 oncogene: Mapping and expression in centrocytic lymphoma","volume":"88","author":"Rosenberg","year":"1991","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0080","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1991.tb08582.x","article-title":"Non-Hodgkin\u2019s lymphomas with t(11;14)(q13;q32). A subset of mantle zone\/intermediate lymphocyte lymphoma","volume":"77","author":"Leroux","year":"1991","journal-title":"Brit J Haematol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0085","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V81.11.3063.3063","article-title":"Rearrangement and over-expression of the BCL-1\/PRAD-1 gene in intermediate lymphocytic lymphomas in in t(11q13)-bearing leukemias","volume":"81","author":"Rimokh","year":"1993","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0090","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood.V76.7.1387.1387","article-title":"Genotypic characterization of centrocytic lymphoma: Frequent rearrangement of the chromosome-11 bcl-1 locus","volume":"76","author":"Williams","year":"1990","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0095","series-title":"Neoplastic Hematology","first-page":"617","article-title":"Mantle cell lymphoma","author":"Weisenburger","year":"1992"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0100","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00000478-199207000-00001","article-title":"Mantle cell lymphoma A proposal for unification of morphologic, immunology, and molecular data","volume":"16","author":"Banks","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0105","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood.V78.2.259.bloodjournal782259","article-title":"bcl-1, t(11;14), and mantle cell-derived lymphomas","volume":"78","author":"Raffeld","year":"1991","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0110","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American Classification of lymphoid neoplasms. A proposal from the International Lymphomas Study Group","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0115","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/oxfordjournals.annonc.a058904","article-title":"European Lymphoma Task Force (ELTF): Report of the workshop on Mantle Cell Lymphoma (MCL)","volume":"5","author":"Zucca","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0120","doi-asserted-by":"crossref","unstructured":"The Non-Hodgkin\u2019s Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin\u2019s lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982; 49: 2112\u201335.","DOI":"10.1002\/1097-0142(19820515)49:10<2112::AID-CNCR2820491024>3.0.CO;2-2"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0125","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1182\/blood.V83.10.2829.2829","article-title":"Nonfollicular small B-cell lymphomas: A heterogenous group of patients with distinct clinical features and outcome","volume":"83","author":"Berger","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1093\/oxfordjournals.annonc.a059148_bb0130","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/oxfordjournals.annonc.a059154","article-title":"Mantle cell lymphoma: Natural history defined in a serially biopsied population over a 20-year period","volume":"6","author":"Norton","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0135","doi-asserted-by":"crossref","unstructured":"The International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin\u2019s lymphoma N Engl J Med 1993; 329: 987\u201394.","DOI":"10.1056\/NEJM199309303291402"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0140","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1200\/JCO.1991.9.2.211","article-title":"Prognostic factors in aggressive malignant lymphomas. Description and validation of a prognostic index that could identify patients requiring a more intensive therapy","volume":"9","author":"Coiffier","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0145","first-page":"89","article-title":"Prognostic factors in follicular lymphomas","volume":"20","author":"Coiffier","year":"1993","journal-title":"Sem Oncol"},{"issue":"3","key":"10.1093\/oxfordjournals.annonc.a059148_bb0150","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.annonc.a059155","article-title":"Patterns of survival in mantle cell lymphoma","volume":"6","author":"Zucca","year":"1995","journal-title":"Ann Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0268-960X(05)80011-6","article-title":"Mantle cell lymphoma","volume":"8","author":"Vandenberghe","year":"1994","journal-title":"Blood Rev"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0160","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hon.2900070505","article-title":"Multicentre randomized therapeutic trial for advanced centrocytic lymphoma: Anthracycline does not improve the prognosis","volume":"7","author":"Meusers","year":"1989","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1093\/oxfordjournals.annonc.a059148_bb0165","first-page":"449a","article-title":"Characteristics and clinical course of follicle center lymphomas and mantle cell lymphomas. A study on the clinical relevance of the REAL. classification","volume":"84","author":"Hiddemann","year":"1994","journal-title":"Blood"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0170","first-page":"181","article-title":"Centrocytic lymphoma: A distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse","volume":"113","author":"Swerdlow","year":"1983","journal-title":"Am J Pathol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0175","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/10428199409051659","article-title":"Treatment and prognosis of centrocytic (mande cell) lymphoma. A retrospective analysis of 26 patients treated in one institution","volume":"13","author":"Zucca","year":"1994","journal-title":"Leuk Lymph"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0180","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/bjc.1991.253","article-title":"Fludarabine phosphate for the treatment of low grade lymphoid malignancy","volume":"64","author":"Whelan","year":"1991","journal-title":"Brit J Cancer"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0185","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/hon.2900020306","article-title":"Clinical and prognostic relevance of the Kiel classification of non-Hodgkin\u2019s lymphomas. Results of a prospective multicenter study by the Kiel Lymphoma Study group","volume":"2","author":"Brittinger","year":"1984","journal-title":"Hematol Oncol"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0190","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/82.9.742","article-title":"Lymphocytic lymphoma of intermediate differentiation. Morphologic, immunophenotypic, and prognostic factors","volume":"82","author":"Bookman","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJM199308123290703","article-title":"Radioimmunotherapy of B-cell lymphoma with [I-131]anti-B1 (anti-CD20) antibody","volume":"329","author":"Kaminski","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/oxfordjournals.annonc.a059148_bb0200","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/oxfordjournals.annonc.a058451","article-title":"Interferon alpha-recombinant in the treatment of follicular lymphoma patients","volume":"4","author":"Coiffier","year":"1993","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1093\/oxfordjournals.annonc.a059148_bb0205","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/oxfordjournals.annonc.a059156","article-title":"The role of high-dose therapy and autologous hematopoietic stem cell transplantation for mantle cell lymphoma","volume":"6","author":"Stewart","year":"1995","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419611579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/6\/3\/208\/371623\/6-3-208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T20:12:18Z","timestamp":1582229538000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419611579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["S0923753419611579"],"URL":"https:\/\/doi.org\/10.1093\/oxfordjournals.annonc.a059148","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}